69 related articles for article (PubMed ID: 24825912)
1. ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma.
Tulalamba W; Larbcharoensub N; Janvilisri T
J Clin Pathol; 2014 Aug; 67(8):667-72. PubMed ID: 24825912
[TBL] [Abstract][Full Text] [Related]
2. ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance.
Galanakis I; Spyropoulos E; Gkialas I; Nomikos A; Souka E; Mitropoulos D
J BUON; 2013; 18(3):653-9. PubMed ID: 24065479
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
[TBL] [Abstract][Full Text] [Related]
4. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.
Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016
[TBL] [Abstract][Full Text] [Related]
5. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
7. ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer.
Moghbeli M; Makhdoumi Y; Soltani Delgosha M; Aarabi A; Dadkhah E; Memar B; Abdollahi A; Abbaszadegan MR
Biol Res; 2019 Jan; 52(1):2. PubMed ID: 30621788
[TBL] [Abstract][Full Text] [Related]
8. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma.
Liu S; Geng R; Lin E; Zhao P; Chen Y
Front Genet; 2021; 12():602160. PubMed ID: 33732282
[TBL] [Abstract][Full Text] [Related]
9. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
[TBL] [Abstract][Full Text] [Related]
10. [Relationship of expression of C-erbB2, C-erbB3, and C-erbB4 with ovarian carcinoma].
Li L; Zhong YP; Zhang W; Zhang JQ; Yao ZQ
Ai Zheng; 2004 May; 23(5):568-72. PubMed ID: 15142456
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma.
Luo WR; Wu AB; Fang WY; Li SY; Yao KT
Histopathology; 2012 Aug; 61(2):237-46. PubMed ID: 22385354
[TBL] [Abstract][Full Text] [Related]
12. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
[TBL] [Abstract][Full Text] [Related]
13. Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.
Wang J; Kang M; Qin YT; Wei ZX; Xiao JJ; Wang RS
Int J Clin Exp Pathol; 2015; 8(6):6936-43. PubMed ID: 26261581
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.
Liu Y; Liu Q; Wang Z; Chen M; Chen Y; Li X; Huang D; Fan S; Xiong W; Li G; Zhang W
J Clin Lab Anal; 2020 Aug; 34(8):e23298. PubMed ID: 32697404
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of twist expression in nasopharyngeal carcinoma.
Song LB; Liao WT; Mai HQ; Zhang HZ; Zhang L; Li MZ; Hou JH; Fu LW; Huang WL; Zeng YX; Zeng MS
Cancer Lett; 2006 Oct; 242(2):258-65. PubMed ID: 16412561
[TBL] [Abstract][Full Text] [Related]
16. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
17. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells.
Zhang W; Zeng Z; Wei F; Chen P; Schmitt DC; Fan S; Guo X; Liang F; Shi L; Liu Z; Zhang Z; Xiang B; Zhou M; Huang D; Tang K; Li X; Xiong W; Tan M; Li G; Li X
FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098
[TBL] [Abstract][Full Text] [Related]
18. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
19. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma.
Chang SL; Chen TJ; Lee YE; Lee SW; Lin LC; He HL
Int J Med Sci; 2018; 15(10):992-998. PubMed ID: 30013440
[No Abstract] [Full Text] [Related]
20. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
Zhao GG; Xiang XJ; He YJ
Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]